Bethesda, MD, United States of America

David Rodbard

This inventor holds 1 USPTO granted patent. Top assignee: The United States of America as Represented by the Secretary of. Active years: 1984.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Rodbard. Retrieved from https://idiyas.com/inventor/david-rodbard-y03olg7j

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1984

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of David Rodbard

Introduction

David Rodbard is an accomplished inventor based in Bethesda, MD (US). He has made significant contributions to the field of pharmacology, particularly through his innovative work on enkephalins. His research has implications for understanding opiate receptors and developing analgesic agents.

Latest Patents

David Rodbard holds a patent for "Dimeric enkephalins." This invention involves symmetrical dimers of enkephalin polypeptides, which are linked at the C-termini with a difunctional amino bridging group. These compounds serve as valuable investigative tools for probing opiate receptor membranes, especially as radiolabelled ligands for exploring the delta opiate receptor. Additionally, they have potential applications as narcotic and/or analgesic agents. He has 1 patent to his name.

Career Highlights

David Rodbard has had a distinguished career, working for the United States of America as Represented by the Secretary of. His work has been pivotal in advancing the understanding of pain management and the mechanisms of opiate receptors.

Collaborations

Throughout his career, David has collaborated with notable colleagues, including Y Shimohigashi and Hao-Chia Chen. These partnerships have contributed to the depth and breadth of his research.

Conclusion

David Rodbard's innovative work in the field of pharmacology, particularly with dimeric enkephalins, showcases his commitment to advancing medical science. His contributions continue to influence research and development in analgesic therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…